Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 5, 1996, Pages 801-806

  Forrest, E H ^a   Stanley, A J ^a   Redhead, D N ^a   McGilchrist, A J ^a   Hayes, P C ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASCITES; BLEEDING; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MORTALITY; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL;

EID: 0029821712     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.60202000.x     Document Type: Article

References (20)

1. Jalan R, Redhead DN, Simpson KJ, Elton RA, Hayes PC. Transjugular intrahepatic portosystemic stent-shunt (TIPSS): longterm follow-up. Q J Med 1994; 87: 565-73.
2. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Roes J. Peripheral arterial vasodilatation hypothesis : a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-7.
3. Somberg KA, Lake JR, Tomlanovich SJ, LaBerge JM, Feildstein V, Bass NM. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995; 21: 709-16.
4. Quiroga J, Sangro B, Nunez M, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effects on clinical, renal, humoral, and haemodynamic parameters. Hepatology 1995; 21: 986-94.
5. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332: 1192-7.
6. Ferral H, Bjarnason H, Wegryn SA, et al. Refractory ascites: early experience in treatment with transjugular intrahepatic portal-systemic shunt. Radiology 1993; 189: 795-801.
7. Wong F, Sniderman K, Liu P, Allidina Y, Sherman M, Blendis L. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995; 122: 816-22.
8. Hills C, Miller LS, Ter H, et al. Increased colloid pressure correlates with resolution of refractory ascites after transjugular intrahepatic portal-systemic shunt (TIPS). Hepatology 1995; 22(Suppl.): 165A (Abstract).
9. Thuluvath PJ, Mitchell S, Prescott C, Osterman F. TIPSS for refractory ascites and advanced cirrhosis. Hepatology 1995; 22(Suppl.): 165A (Abstract).
10. Shrestha R, Durham JD, Kumpe DA, et al. Outcome after transjugular intrahepatic portal-systemic shunt for refractory ascites in patients with advanced cirrhosis. Hepatology 1995; 22(Suppl.): 165A (Abstract).
11. Sezai S, Kamisaka K, Hirano M. Effectiveness of transjugular intrahepatic shunt (TIPS) for refractory ascites. Hepatology 1995; 22(Suppl.): 489A (Abstract).
12. LeBrec D, Guilly N, Hadengue A, et al. Transjugular intrahepatic portal-systemic shunt (TIPS) versus paracentesis for refractory ascites. Results of a randomised trial. Hepatology 1994; 20(Suppl.): 201a (Abstract).
13. Peron JM, Rousseau H, Vinel JP, et al. TIPS in the treatment of refractory ascites: results in 31 consecutive patients with cirrhosis. Gastroenterology 1995; 108(Suppl.): A1145 (Abstract).
14. Benner KG, Sahagun G, Saxon R, et al. Selection of patients undergoing transjugular intrahepatic portal-systemic shunts (TIPS) for refractory ascites. Hepatology 1994; 20(Suppl.): 114a (Abstract).
15. Gordon FD, Stokes KR, Falchuk KR, et al. Transjugular intrahepatic portosystemic shunt (TIPSS) for the treatment of refractory ascites. Gastroenterology 1993; 106(Suppl.): 900a (Abstract).
16. Pomier-Layrargues G, Legault L, Roy L, Dufresne PM, Lafortune M, Fenyves D. TIPSS for treatment of refractory ascites: a pilot study. Hepatology 1993; 18(Suppl.): 103a (Abstract).
17. Arroyo V, Epstein M, Gallus G, et al. Refractory ascites in cirrhosis: mechanism and treatment. Gastroenterol Int 1989; 2: 195-207.
18. Gentilini P, Laffi G. Pathophysiology and treatment of ascites and the hepatorenal syndrome. Baill Clin Gastroenterol 1992; 6: 581-607.
19. Azoulay D, Castaing CA, Dennison A, Martino W, Eyraud D, Bismuth H. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 1994; 19: 129-32.
20. LaBerge JM, Somberg KA, Lake JR, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108: 1143-51.